Cefrock T 250mg/31.25mg Injection
Marketer
Pinarc Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefrock T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg injection combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare professional, this dual-action medication requires adherence to the prescribed dosage schedule. Complete the entire course, even with symptom improvement, to ensure efficacy. Premature cessation may reduce its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions like rash, itching, swelling, or respiratory distress. Disclose all current medications to your physician before commencing treatment, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Sufficient rest, proper nutrition, and hydration are recommended for optimal recovery. Your doctor might order tests to monitor the medicine's impact.
Primary Ingredients of Cefrock T 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Cefrock T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefrock T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefrock T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefrock T 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified assistant; please do not attempt self-medication.
How Cefrock T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefrock T 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Cefrock T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Cefrock T 250mg/31.25mg injections are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefrock T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefrock T 250mg/31.25mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefrock T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Cefrock T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefrock T 250mg/31.25mg Injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Cefrock T 250mg/31.25mg Injection :
Omit a Cefrock T 250mg/31.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefrock T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently